title: [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease].
abstract: OBJECTIVE
  To measure the levels of human alpha-defensin 1-3 (HNP1-3) in the serum and induced sputum in patients with chronic obstructive pulmonary disease (COPD) and therefore to investigate the possible roles of HNP1-3 in COPD.
  
  
  METHODS
  Thirty patients with acute exacerbation of COPD, 21 patients with stable COPD, and 22 healthy subjects were recruited. The concentrations of HNP1-3 and interleukin-8 (IL-8) in serum and induced sputum were measured by enzyme-linked immunosorbent assay (ELISA). The correlations among HNP1-3, neutrophils, IL-8, and lung functions were investigated. The data were analyzed using a statistical software package (SPSS 11.5). Variables were compared with One-Way ANOVA or Chi-square test. The correlations between variables were analyzed using Pearson's correlation coefficient or Spearman correlation coefficient.
  
  
  RESULTS
  The sputum HNP1-3 level was significantly higher in AECOPD patients [9,652(4,272 -12,576) ng/L] than in healthy subjects [4,194 (700 -10,505) ng/L, chi2 =7.53, P <0.01] and in stable COPD patients [7,011(6,658 -7,319) ng/L, chi2 = 10.24, P <0.01]. There was significant difference among the three groups (chi2 =7.31, P <0.05). There was no significant difference in the serum HNP1-3 level among the three groups: AECOPD group [51(39 - 173) ng/L], stable COPD group [135(113 - 241) ng/L], healthy subjects group [130(13 - 160) ng/ L], chi2 = 5.75, P > 0.05. The sputum HNP1-3 level was positively correlated with the number, percentage of sputum neutrophils, and sputum IL-8 level (r = 0.29 to 0.53, respectively P <0.01). The sputum HNP1-3 level was negatively correlated with FEV1/predicted values, FEV1/FVC, and PaO2 (r= -0.33 to -0.44, respectively P <0.01).
  
  
  CONCLUSIONS
  HNP1-3 may be involved in the pathogenesis of airway inflammation in COPD. Sputum HNP1-3 may be a noninvasive marker of severity of COPD.
authors.affiliation: Department of Respiratory Medicine, Peking University Third Hospital, Beijing 100083, China.
authors.forename: Zhuo
authors.initials: Z
authors.lastname: Wang
authors.forename: Wan-Zhen
authors.initials: WZ
authors.lastname: Yao
authors.forename: Guo-Guang
authors.initials: GG
authors.lastname: Xia
authors.forename: De-Jun
authors.initials: DJ
authors.lastname: Sun
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D016209:Interleukin-8; D007958:Leukocyte Count; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000378:metabolism*; D012907:Smoking; D013183:Sputum / Q000378:metabolism; D023084:alpha-Defensins / Q000097:blood* / Q000378:metabolism*
chemical_list: D016209:Interleukin-8; D023084:alpha-Defensins